Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Covid 19: Will pain-free, at-home screening tests be our salvation?

The world’s best defence against the spread of COVID-19 in 2021 will not be a vaccine, medical experts now say. Instead, it will be the widespread adoption of cheap, non-invasive diagnostic detection devices for coronaviruses – ones that look and function...

Buzz on the Bullboards: Stocks making headlines

It can be hard to know when to make a move when every day looks crazier than the last. Traders don’t not know what to expect coming in tomorrow’s news cycle … but you can bet the markets are going to be volatile day-to-day. This has bee...

Novo Scores +1 Gram Per Meter at Egina

It's been eight months since I have delivered an update on Novo Resources Corp. (NVO:TSX.V; NSRPF:OTCQX) . While Novo has put out a fair number of press releases since then I have been waiting for some solid red meat. They have just put out red meat that should satis...

US between Scylla and Charybdis

I’m just going to come right out and say it: The United States is not equipped to deal with a pandemic. The nation of 327 million, despite having the number one economy in the world, and by far the most powerful military, is shockingly ill-prepared, not only ...

Buzz on the Bullboards: New Rising Opportunities

There has been a lot of attention on the tech sector and the stocks working in that marketplace as of late. Despite market volatility, the tech-heavy Nasdaq has displayed much growth this year as it dug itself out of the COVID hole that had investors and the markets at large p...

Feb 12th 2020, Crypto Chartbook – Consistently extracting profits

Consistently extracting profits In our chartbook publication from last week we published a chart with entry levels as a guide on when to enter the market. Briefly after publication, the first low risk price level was approached. Consequently we posted a screen...

PCR Testing: XPhyto Disrupts a Blockbuster Business

It’s the technological evolution that could transform the US $84.4 billion Covid-19 diagnostics market. Vancouver-based life sciences company XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) (OTC: XPHYF) expects its rapid Covid-19 test system to be approv...

AIM ImmunoTech Shares Soar as Japan's NIID Tests Ampligen® as Potential Coronavirus Treatment

Shares of AIM ImmunoTech traded more than 150% higher after the company reported that Japan's National Institute of Infectious Diseases will test its Ampligen® drug as a potential treatment for the coronavirus. Immuno-pharmaceutical company AIM Imm...

Buzz on the Bullboards: COVID-19 Testing Plays

There are many investing plays that are attractive to serious investors and small-cap opportunists in the current market, but coronavirus movements take the cake. We’ve noted that each sector has its share of positive opportunities for both long-term and sh...

A Market ‘Game Changer’ for Rapid COVID-19 At-Home Testing?

(Click image to play video) While we can finally see light at the end of the tunnel in the fight against COVID-19, the global pandemic has invariably changed how we interact with the world around us. The two big names when it comes to fighting the virus are ...
1 2 3 4 5 6 7 8 9 10 ...